Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
  • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
  • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
  • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
  • A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
  • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
  • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
  • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
  • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
  • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves

Definitions

• the present invention relates to a heart valve sewing ring that is highly compatible with surrounding tissue and, in particular, to a sewing ring made of a material that has physical properties similar to the surrounding tissue.
• Heart valve disease continues to be a significant cause of morbidity and mortality, resulting from a number of ailments including rheumatic fever and birth defects. Recent statistics show that valvular heart disease is responsible for nearly 20,000 deaths each year in the United States, and is a contributing factor in approximately 42,000 deaths. Currently, the primary treatment of aortic valve disease is valve replacement. Worldwide, there are approximately 300,000 heart valve replacement surgeries performed annually.
• Prosthetic valves attach to the patient's fibrous heart valve annulus, with or without the leaflets being present.
• Replacement heart valves whether mechanical or bioprosthetic, typically utilize sewing rings or cuffs for attachment of the valve within the annulus.
• Sewing rings are generally composed of silicone, expanded PTFE, woven polyester fabric (e.g., polyethylene terepthalale or Dacron), silk, Prolene, and other fiber or fabric materials or combinations of these materials. These materials sometimes induce the surrounding annular tissue to thicken or proliferate (hyperplasia or pannus formation). Sewing rings can also trigger short- term thrombosis and occlusion as well as the longer-term occlusion resulting from tissue hyperplasia and still longer-term atherosclerosis.
• the present invention provides a sewing ring that is highly compatible with surrounding tissue and reduces the formation of pannus.
• the sewing ring is formed from an "iso-elastie" polymeric material having an elastic modulus between about 100 to 10,000 psi, a tensile strength between about 5000 and 60,000 psi, and a tensile elongation between about 100 to 3000%.
• the material desirably has an elastic modulus between about 200 to 2000, a tensile strength between about 5000 to 50,000 psi, and a tensile elongation of between about 100 to 1000%.
• the sewing ring may comprise the material and at least one reinforcing fiber embedded within, such as a fiber of polypropylene.
• the sewing ring comprises a plurality of fibers formed in a mat.
• the material is a polyurethane.
• FIG. 1 is a perspective view of a prosthetic heart valve having a sewing ring of the present invention
• Fig. 2 is a radial cross-sectional view through an exemplary sewing ring seen in Fig. 1;
• Figs. 3A-3C are graphs of elastic modulus, tensile strength, and tensile elongation, respectively, of the iso-elastic materials of the present invention versus conventional sewing ring materials.
• the present invention provides a sewing ring or suture cuff for prosthetic heart valves that is highly compatible with surrounding tissue. It should be understood that the tissue with which the sewing rings are compatible is healthy tissue, as opposed to calcified or stenotic tissue. The elasticity of heart tissue can vary depending on the specific tissue (myocardial, aortic wall, etc.). But in all cases, it is very clastic and stretchy compared to the various materials currently used for sewing ring construction.
• the leaflets or annulus of a patient's heart become highly calcified leading to the need for a replacement valve.
• the healthy tissue around the annulus sometimes exhibit hyperplasia, or proliferation, resulting from the response of local blood vessels to any compatible structure.
• the stiffness of conventional materials for sewing rings, such as fabric and expanded PTFE are many tens to hundreds times the stiffness of the host tissue to which they are engaged. ⁇ local stress concentration due to the mis-match of stiffness (compliance) properties has been identified as the one of the causes of such hyperplasia. Excess tissue proliferation, including excess pannus, can interfere with proper functioning of the prosthetic heart valve.
• the present invention provides an "iso-elastic" sewing ring.
• This term refers to an elasticity similar to that of soft tissue, in contrast to the very stiff prolene, nylon, silk, Dacron, and even PTFE (Teflon). It should be understood, however, that any polymeric fiber or material that has such physical properties is encompassed by the present invention.
• Exemplary materials include silicone, polyurethane, polyurethane copolymers, rubber, and other hemocompatible and biocompatible thermoplastic elastomers.
• the present invention is a prosthetic heart valve sewing ring formed from a material selected from the group consisting of any polymer having an elastic modulus between about 100 to 5000, up to 10,000 psi, and more preferably between 200 to 2000 psi.
• the material also has a tensile strength between about 5000 and 60,000 psi, and more particularly between about 5000 to 50,000 psi.
• the tensile elongation of the material is desirably between about 100 to 3000%, preferably between about 100 to 1000%.
• FIG. 1 illustrates an exemplary heart valve 20 in perspective view having a sewing ring 22 of the present invention.
• the heart valve 20 may have flexible leaflets, such as bioprosthetic tissue, or may be a mechanical valve with rigid leaflets.
• the sewing ring 22 can be a planar, annular construct, or have an undulating peripheral shape as shown.
• the sewing ring 22 can have a solid cross-section section as shown, or can be provided with open cells to encourage tissue ingrowth.
• One embodiment is a fibrous mat formed from fibers having the material properties described herein.
• the material of the sewing ring 22 is iso-elastic vis-a-vis the surrounding tissue, and therefore adverse reactions with surrounding tissue and thus excess tissue overgrowth is minimized.
• the sewing ring 22 attaches to the valve body in a similar manner as current sewing rings, as known to those skilled in the art. For example, sutures may attach the sewing ring 22 to the valve body, or a fabric-covered portion thereof.
• the sewing ring 22 has no outer fabric covering, which is the case with current sewing rings, and is desirably monolithic.
• fabric or fibers 24 such as polypropylene sutures may be embedded within the sewing ring 22. These fibers do not contact the surrounding tissue, and therefore do not reduce the tissue compatibility of the sewing ring 22. The libers 24 do, however, provide reinforcing strength to the sewing ring 22 to help prevent suture pull-out. Due to the greater elasticity of the sewing ring 22 material, the density of the fabric/fiber
• iso-elastic sutures such as those disclosed in U.S. Patent No. 6,197,043 to Davidson are utilized.
• the disclosure of U.S. Patent No. 6,197,043 Is incorporated herein to the extent It discloses alternative "iso-elastic" materials.
• the graphs of Figs. 3A-3C illustrate the relative physical properties of the iso-elastic materials of the present invention versus conventional sewing ring materials. Ranges of possible values for these properties for the iso-elastic material are provided, as are property ranges for typical sewing ring materials. It is important to understand that any polymer having the qualities described herein may be a candidate for an Iso-elastic sewing ring. For example, silicone is typically used in conventional sewing rings, albeit in a form that Is not iso-elastic vis-a-vis the surrounding tissue. Therefore, the graphs described property ranges for the class of silicone currently used in sewing rings. Similarly, property ranges are provided for the type of Dacron that is present used for sewing rings. However, these materials can be modified to fall within the exemplary ranges for an iso- elastic material. Therefore, the comparison illustrated by the graphs should not be construed to exclude any of these materials per se, only these materials having certain properties.
• the inventive sewing ring 22 can also be treated with antithrombotic agents such as heparin, hyaluronan, phosphorylcholine, platelet factors, peptides, and other proteins.
• antithrombotic agents such as heparin, hyaluronan, phosphorylcholine, platelet factors, peptides, and other proteins.
• Such agents can be impregnated or processed into the polymer sewing ring material as well as being coated on or added to the exterior surface to improve hemocompatibility.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Chemical & Material Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Transplantation (AREA)
• Animal Behavior & Ethology (AREA)
• Dermatology (AREA)
• Epidemiology (AREA)
• Medicinal Chemistry (AREA)
• Biomedical Technology (AREA)
• Cardiology (AREA)
• Vascular Medicine (AREA)
• Materials Engineering (AREA)
• Composite Materials (AREA)
• Heart & Thoracic Surgery (AREA)
• Materials For Medical Uses (AREA)
• Prostheses (AREA)

Priority Applications (3)

Applications Claiming Priority (2)

Publications (2)

Family

ID=38786949

Family Applications (1)

Country Status (6)

Families Citing this family (8)

Family Cites Families (11)

• 2006
  • 2006-07-24 US US11/491,593 patent/US20080021547A1/en not_active Abandoned
• 2007
  • 2007-07-03 CN CNA2007800279643A patent/CN101495064A/zh active Pending
  • 2007-07-03 WO PCT/US2007/072793 patent/WO2008014093A2/en not_active Ceased
  • 2007-07-03 EP EP07840347A patent/EP2046245A2/en not_active Withdrawn
  • 2007-07-03 CA CA002657707A patent/CA2657707A1/en not_active Abandoned
  • 2007-07-03 JP JP2009521882A patent/JP2009544415A/ja active Pending

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events